Implication of JAK1, JAK2, and JAK3 in the Realization of Proliferation and Differentiation Potential of Mesenchymal Progenitor Cells In Vitro


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Involvement of individual JAK kinases in the realization of growth potential of mesenchymal progenitor cells was examined in vitro. Important role of JAK2 and JAK3 in determining the initial level of mitotic activity of progenitor cells was established. The yield of fibroblast CFUF was suppressed under the effect of specific inhibitors of JAK kinases. Blockade of JAK3 increased the rate of progenitor element differentiation. JAK1 had no effect on proliferation and differentiation status of progenitor cells.

About the authors

G. N. Zyuz’kov

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; National Research Tomsk State University

Author for correspondence.
Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk; Tomsk

V. V. Zhdanov

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk

E. V. Udut

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk

L. A. Miroshnichenko

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk

E. V. Simanina

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk

T. Yu. Polyakova

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk

A. V. Chaikovskii

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk

L. A. Stavrova

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk

V. V. Udut

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine; National Research Tomsk State University

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk; Tomsk

V. I. Agafonov

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk

Ya. V. Burmina

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk

M. G. Danilets

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk

M. Yu. Minakova

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk

A. M. Dygai

E.D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: zgn@pharm.tsu.ru
Russian Federation, Tomsk


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies